Atlas Antibodies Blog

A historical gender gap at all levels of science, technology, engineering and mathematics continues to persist in much of our society to this day. Although at Atlas Antibodies we have a diverse team of men and women at all levels of the organization, worldwide, women only account for less than 30% of researchers and male researchers often reach more senior roles or are paid more.

This month we celebrate the second anniversary of our blog. If you have missed it read on. Here is a recap just for you.

Dysfunctional nuclear-cytoplasmic trafficking of RNA binding proteins might contribute to neurological disorders. For this blog post we spoke with Dr. Rita Sattler.She employs human patient-derived induced pluripotent stem cells to elucidate the nuclear-cytoplasmic trafficking mechanisms in neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Drug repurposing is the strategy of using existing drugs originally developed for a specific disease to treat other diseases. Today we spoke with Dr. Joanna Zawacka-Pankau, PhD in biochemistry. We asked her about her research efforts in drug repurposing to treat cancer.

This month we celebrate the first anniversary of our blog. It has been an incredible journey. If you have missed our blog posts, read on. We have interviewed scientists, discussed the importance of antibodies validation, the human protein atlas project and we gave you advice on how to succeed with your immunohistochemistry.